Loading...
XOSL
CONTX
Market cap32mUSD
Aug 28, Last price  
4.08NOK
Name

ContextVision AB

Chart & performance

D1W1MN
XOSL:CONTX chart
P/E
409.73
P/S
2.82
EPS
0.01
Div yield, %
Shrs. gr., 5y
-0.36%
Rev. gr., 5y
3.08%
Revenues
Net income
CFO
Dividend
Nov 02, 20230.15293 NOK/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

ContextVision AB (publ), a medical technology enterprise established in Stockholm, Sweden, in 1983, delivers sophisticated software solutions. The firm specializes in image analysis and artificial intelligence, supplying these advanced technologies to original equipment manufacturers (OEMs) across Asia, Europe, and the United States. Their comprehensive product suite is designed to optimize image quality across various medical imaging modalities, including two-dimensional, three-dimensional, and four-dimensional ultrasound, radiography, magnetic resonance imaging (MRI), and mammography. Key offerings include: Rivent: Provides superior image quality for a broad spectrum of ultrasound applications such as women's health, general imaging, cardiovascular, and point-of-care. VolarView: An image enhancement software specifically developed for the burgeoning handheld ultrasound market. GOPiCE: A proprietary technology enabling real-time volumetric image enhancement. Altumira/Altumira Plus: A robust platform for digital radiography. An Orthopedic Package: Tailored for specialized orthopedic imaging needs. GOPView MRI2Plus: An advanced solution for MRI image improvement. INIFY Prostate Screening: Offers digital analysis for prostate biopsies.
IPO date
Mar 06, 1997
Employees
36
Domiciled in
SE
Incorporated in
SE

Valuation

No data to show